HMGB1 and non-small cell lung carcinoma: In addition, high mobility group box 1 (HMGB1) and interferon-1 (IFN-I) were also investigated in patients with NSCLC whom have been treated with radiotherapy alone or in combination with immunotherapy (Ipilimumab), respectively.